6-MP has been demonstrated to be effective in the treatment of inflammatory diseases such as inflammatory bowel disease, rheumatoid arthritis and asthma, probably through modulation of the NFκB pathway [17, 29, 31]. Here, NFKB1 is linked to inflammatory bowel disease.